Clin2
NCT07232095Likely a fitRecruiting

7-Day treatment for H. pylori with new acid blocker and antibiotics

Helicobacter Pylori

Part of Digestive system clinical trials.

This trial tests a 7-day combination of vonoprazan, high-dose amoxicillin, and bismuth to treat Helicobacter pylori infection in people who have never been treated for it before. The goal is to see if this short course is effective and safe for curing the infection.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 4
Enrollment
316 people
Ages
18 years to 70 years
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old.
  • You have tested positive for H. pylori in the last month using a breath test.
  • You have chronic gastritis confirmed by an endoscopy in the last 3 months and need treatment based on current guidelines.
  • You have never been treated for H. pylori before.
  • You are willing to take the study medications and follow the study schedule.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07122024Recruiting· Phase 4
Testing a dual therapy for H. pylori treatment

This trial tests a two-drug treatment (keverprazan and amoxicillin) for people who have H. pylori and have not been treated for it before. The goal is to see if this newer combination works well and is safe.

Hangzhou, Zhejiang
NCT07537634Recruiting· Phase 4
New stomach acid medicine versus standard treatment for H. pylori infection

This trial compares two different antibiotic combinations to treat H. pylori, a common stomach bacteria that causes indigestion and ulcers. One uses a newer acid-blocking medicine (vonoprazan) and the other uses a standard one (esomeprazole), both paired with antibiotics.

Dhaka
NCT06929962Recruiting· Phase 4
VA dual sequential therapy for H. pylori gastritis

This trial tests a new two-step antibiotic treatment for adults with chronic gastritis caused by H. pylori bacteria. If you have not been treated for H. pylori before and are between 18 and 70, you may be able to join.

Nanjing, Jiangsu
NCT07352098Not yet recruiting
Shorter treatment for H. pylori infection

This trial compares a 7-day treatment with a 14-day treatment for H. pylori infection. Both use the same two medicines. The goal is to see if the shorter treatment works just as well and is easier for patients.

Kashgar, Xinjiang
NCT07757919Not yet recruiting· Phase 4
14-day treatment for H. pylori infection

This trial tests a 14-day course of two medicines, vonoprazan and minocycline, to see how well they clear an H. pylori stomach infection. If you have H. pylori and haven't been treated for it before, this study may help you get rid of the infection.

NCT07720037Not yet recruiting· Phase 4
Shorter high-dose treatment for H. pylori infection

This trial compares two short courses of medicine to get rid of an H. pylori stomach infection: a 10-day higher-dose treatment versus a 14-day standard-dose treatment. Both use two medicines (vonoprazan and amoxicillin) to see which works just as well with a shorter time frame.

Hear when a new Helicobacter Pylori trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.